Gene-edited cells that evade rejection show promise in type 1 diabetes

Share This Post


A transmission electron micrograph of a section through pancreas tissue, showing cells that produce insulin

STEVE GSCHMEISSNER/SCIENCE PHOTO LIBRARY/Alamy

The first human trial of insulin-producing cells that have been gene-edited to evade immune attack is a success so far. The cells have survived and produced insulin for a month after being injected into a 42-year-old man with type 1 diabetes early in December.

As a precaution, only a small number of insulin-producing beta cells were injected into a forearm muscle in this initial test, so the man still needs insulin injections. It also remains to be seen how long the…



Source link

spot_img

Related Posts

6 genuinely helpful uses for the USB port on your router

The USB port on your router is often...

Crypto Scams Likely Set New Record in 2024, Helped by AI: Chainalysis

The rise of "pig butchering" scams and the...

China’s Xi Jinping attends symposium on private enterprises

China's President Xi Jinping has attended a symposium...

ESA astronaut with physical disability medically cleared for ISS missions

WASHINGTON — In a first, a European astronaut...

Like it or not, AI is learning how to influence you

Join our daily and weekly newsletters for the...
spot_img